financetom
Business
financetom
/
Business
/
Zilingo's Ankiti Bose to become the first Indian woman CEO of a unicorn, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zilingo's Ankiti Bose to become the first Indian woman CEO of a unicorn, says report
Feb 13, 2019 1:51 AM

Ankiti Bose, the co-founder of fashion e-commerce platform Zilingo, is all set to become the first Indian woman CEO of a unicorn, reported The Times of India.

The development emerged after the four-year-old startup was valued at about $970 million in its latest round, reported ToI, citing sources. This, the report added, would make Bose, who graduated from St Xavier’s College, Mumbai, the first Indian female co-founder and CEO of a high-valued startup venture.

Bose’s startup, based at Singapore, collected $226 million in the latest round from venture capital firm Sequoia Capital, the report said.

As per the report, the startup has racked up a total $306 million in form of funding.

“Personally, a lot of men have been very helpful to me in my journey. But of course, if you have more women in venture capital and more female entrepreneurs, then things will get a lot better,” Bose was quoted as saying in the report.

The achievement of Bose gains even more significance given the limited support that is received by startups that are led by women in the region. As per the report, Last year, India ranked at 52 on the 57-country list of Mastercard Index for Women Entrepreneurs.

First Published:Feb 13, 2019 10:51 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA declines to approve Outlook Therapeutics' drug for eye condition
US FDA declines to approve Outlook Therapeutics' drug for eye condition
Aug 28, 2025
Aug 28 (Reuters) - The U.S. Food and Drug Administration has declined to approve Outlook Therapeutics' ( OTLK ) experimental drug to treat a type of eye condition that causes blurred vision, the company said on Thursday. ...
Toronto-Dominion Bank Fiscal Q3 Adjusted Earnings, Revenue Rise
Toronto-Dominion Bank Fiscal Q3 Adjusted Earnings, Revenue Rise
Aug 28, 2025
06:32 AM EDT, 08/28/2025 (MT Newswires) -- Toronto-Dominion Bank ( MLWIQXX ) reported fiscal Q3 adjusted earnings Thursday of 2.20 Canadian dollars ($1.60) per diluted share, up from CA$2.05 a year earlier. Analysts surveyed by FactSet expected CA$2.05. Adjusted revenue for the quarter ended July 31 was CA$15.61 billion, up from CA$14.24 billion a year earlier. Analysts surveyed by FactSet...
CrowdStrike Raises Full-Year Earnings Outlook; Issues Third-Quarter Revenue Guidance Below Estimates
CrowdStrike Raises Full-Year Earnings Outlook; Issues Third-Quarter Revenue Guidance Below Estimates
Aug 28, 2025
06:35 AM EDT, 08/28/2025 (MT Newswires) -- CrowdStrike ( CRWD ) lifted its full-year earnings guidance and reported better-than-expected fiscal second-quarter results, but the cybersecurity firm issued a revenue outlook below initial market estimates for the ongoing three-month period, sending its shares down early Thursday. The company anticipates overall revenue to come in between $1.21 billion and $1.22 billion for...
Market Chatter: Nvidia Says 15% US Commission on China Chip Sales Still Unclear
Market Chatter: Nvidia Says 15% US Commission on China Chip Sales Still Unclear
Aug 28, 2025
06:30 AM EDT, 08/28/2025 (MT Newswires) -- Nvidia ( NVDA ) said a proposed Trump administration plan to impose a 15% commission on its AI chip sales to China remains in early discussions and lacks any formal regulatory framework, Bloomberg reported Thursday. According to the report, the company said late Wednesday that the US government has not provided details on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved